Real-World study checks how well venetoclax works for AML patients
NCT ID NCT05215639
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how well the drug Venetoclax works for adults with acute myeloid leukemia (AML) who are not healthy enough for intensive chemotherapy. About 120 patients in Switzerland and Austria took Venetoclax pills daily as part of their normal care. Researchers tracked survival and remission rates over 24 months to see how effective the treatment is in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Venetoclax (a targeted cancer drug taken as a pill)
What this could lead to
If successful, this study could confirm that Venetoclax is a good treatment option for AML patients who cannot tolerate intensive chemotherapy.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It only included patients in Switzerland and Austria, so findings may not apply to other populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duplicate_Universitätsspital Basel /ID# 256509
Basel, Canton of Basel-City, 4031, Switzerland
-
EOC Ospedale Regionale di Bellinzona e Valli /ID# 240663
Bellinzona, Canton Ticino, 6500, Switzerland
-
Hanusch Krankenhaus /ID# 247282
Vienna, 1140, Austria
-
Hirslanden Klinik /ID# 239239
Zurich, Canton of Zurich, 8032, Switzerland
-
Hôpital de Nyon /ID# 240720
Nyon, 1260, Switzerland
-
Hôpital du Chablais, Rennaz /ID# 241895
Rennaz, Canton of Vaud, 1847, Switzerland
-
Inselspital, Universitaetsspital Bern /ID# 239241
Bern, 3010, Switzerland
-
KSW Kantonsspital Winterthur /ID# 239852
Winterthur, Canton of Zurich, 8400, Switzerland
-
Kantonsspital Aarau AG /ID# 251598
Aarau, Canton of Aargau, 5001, Switzerland
-
Kantonsspital Baden /ID# 241896
Baden, Canton of Aargau, 5404, Switzerland
-
Kantonsspital St. Gallen /ID# 239233
Sankt Gallen, Canton of St. Gallen, 9007, Switzerland
-
Klinik Ottakring /ID# 247285
Vienna, State of Vienna, 1160, Austria
-
Klinikum Klagenfurt am Wörthersee /ID# 247304
Klagenfurt, Carinthia, 9020, Austria
-
Krankenhaus der Barmherzigen Brueder Graz /ID# 254121
Graz, Styria, 8020, Austria
-
Landeskrankenhaus Hochsteiermark, Standort Leoben /ID# 254174
Leoben, Styria, 8700, Austria
-
Luzerner Kantonsspital /ID# 239242
Lucerne, Canton of Lucerne, 6000, Switzerland
-
Ordensklinikum Linz GmbH Elisabethinen /ID# 247284
Linz, Upper Austria, 4010, Austria
-
Spitalzentrum Oberwallis /ID# 241897
Brig, Valais, 3900, Switzerland
-
Universitaetsklinikum St. Poelten /ID# 247283
Sankt Pölten, Lower Austria, 3100, Austria